Zurich Cantonal Bank
ADPT icon

Zurich Cantonal Bank’s Adaptive Biotechnologies ADPT Stock Holding History

Zurich Cantonal Bank’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Hold
49,622
– – ﹤0.01% 1522
2026
Q1 		$689K Buy
49,622
+924
+2% +$14.7K ﹤0.01% 1641
2025
Q4 		$791K Buy
48,698
+12,712
+35% +$207K ﹤0.01% 1489
2025
Q3 		$538K Sell
35,986
-565
-2% -$6.88K ﹤0.01% 1699
2025
Q2 		$426K Sell
36,551
-203
-0.6% -$1.84K ﹤0.01% 1761
2025
Q1 		$273K Sell
36,754
-15,521
-30% -$119K ﹤0.01% 1931
2024
Q4 		$313K Buy
+52,275
New +$288K ﹤0.01% 1918
2024
Q2 		– Sell
-21,364
Closed -$68.6K – 2642
2024
Q1 		$68.6K Hold
21,364
– – ﹤0.01% 2507
2023
Q4 		$105K Buy
21,364
+4,715
+28% +$21.5K ﹤0.01% 2431
2023
Q3 		$90.7K Hold
16,649
– – ﹤0.01% 2395
2023
Q2 		$112K Hold
16,649
– – ﹤0.01% 2297
2023
Q1 		$147K Hold
16,649
– – ﹤0.01% 2061
2022
Q4 		$127K Buy
16,649
+3,755
+29% +$29.2K ﹤0.01% 2119
2022
Q3 		$92K Hold
12,894
– – ﹤0.01% 2286
2022
Q2 		$104K Hold
12,894
– – ﹤0.01% 2205
2022
Q1 		$179K Sell
12,894
-951
-7% -$15K ﹤0.01% 1959
2021
Q4 		$388K Buy
13,845
+3,334
+32% +$102K ﹤0.01% 1642
2021
Q3 		$357K Buy
10,511
+11
+0.1% +$398 ﹤0.01% 1516
2021
Q2 		$429K Buy
10,500
+77
+0.7% +$2.99K ﹤0.01% 1312
2021
Q1 		$420K Sell
10,423
-1,156
-10% -$62.6K ﹤0.01% 1340
2020
Q4 		$685K Buy
11,579
+3,271
+39% +$169K ﹤0.01% 1111
2020
Q3 		$404K Hold
8,308
– – ﹤0.01% 1184
2020
Q2 		$402K Buy
+8,308
New +$303K ﹤0.01% 1119

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Zurich Cantonal Bank's ADPT Position: Q2 2026 in Review

Zurich Cantonal Bank held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 49,622 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1522.

Zurich Cantonal Bank first reported a position in ADPT in Q2 2020 and has held it in 23 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Zurich Cantonal Bank held 49,622 shares of Adaptive Biotechnologies worth $1.06M as of Q2 2026.
  • Zurich Cantonal Bank left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1522 holding.
  • Zurich Cantonal Bank first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 23 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.